Smoking and death: the past 40 years and the next 40. by Peto, R

Detection of risk of cancer to man. by Peto, R

CYTO-TOXIC CHEMOTHERAPY IN BREAST-CANCER - REPLY by Peto, R

CLEARED OF FRAUD by Peto, R

Antiplatelet agents in stroke prevention. by Peto, R

IMPROVING CANCER-THERAPY TRIALS by Peto, R

Colorectal cancer. Limitations of trial. by Peto, R

Influence of dose and duration of smoking on lung cancer rates. by Peto, R

EARLY BREAST-CANCER TRIALISTS COLLABORATION by Peto, R

Saturated fat avoidance. by Peto, R

Distorting the epidemiology of cancer: the need for a more balanced overview. by Peto, R

Carcinogenesis as a multistage process--evidence from human studies. by Peto, R

Cancer, genes, and the environment. by Peto, R

Misleading subgroup analyses in GISSI by Peto, R

Why do we need systematic overviews of randomized trials? by Peto, R

Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient care. by Peto, R

Management of breast cancer. by Peto, R

Editorial: Guidelines on the analysis of tumour rates and death rates in experimental animals. by Peto, R

Treating migraine. by Peto, R

Mortality from breast cancer in UK has decreased suddenly. by Peto, R